WHO’s 2025 HIV clinical guidelines simplify and strengthen care by recommending more durable, safer treatment regimens, ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The double-blind trial evaluated the treatment responses of adults with HIV who are ...
Key goals of EHE include, from 2017 to the end of 2025, reducing new HIV infections and diagnoses by 75%, increasing viral suppression among PWH to 95%, and increasing good or better self-rated health ...
At presentation, all children living with HIV younger than five years should be considered as having advanced HIV disease ...
The World Health Organization (WHO) has strongly recommended CD4 testing as the preferred method for identifying advanced HIV ...
The WHO has strongly recommended CD4 testing to identify advanced HIV disease under its 2025 guidelines. Here’s why the test ...
A mix of domestic revenue generation, efficiency gains and strategic partnerships is essential to sustain and expand HIV ...
Cancer is a leading cause of death for people living with HIV; at AANP 2025, experts discuss how to screen for and prevent cancer.
Laparoscopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial We used data from the HIV/AIDS Cancer Match Study, a population-based HIV and cancer registry ...
CD4 tests are strongly recommended as the preferred method to identify advanced HIV disease among people living with HIV, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback